Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.05 is 15% below its 5-year average of 1.24, near the low end of its 5-year range (0.98–2.73).
As of the fiscal period ended Tuesday, June 30, 2026. 3.03% above its 12-month average of 1.02.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.05.
CURRENT RATIO
1.05
CURRENT RATIO AVG TTM
1.02
CURRENT RATIO AVG 3Y
1.25
CURRENT RATIO AVG 5Y
1.24
CURRENT RATIO AVG 10Y
1.03
CURRENT RATIO AVG 15Y
0.85
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+3.03%
CURRENT VS 3Y AVG
-15.50%
CURRENT VS 5Y AVG
-15.25%
CURRENT VS 10Y AVG
+2.19%
CURRENT VS 15Y AVG
+23.91%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 500 covered companies
CURRENT VS SECTOR MEDIAN
-68.63%
vs the sector median at left
Market Cap
$18.77M
Current Ratio
0.20
TTM Avg
0.34
3Y Avg
6.34
5Y Avg
6.11
Market Cap
$20.93M
Current Ratio
1.25
TTM Avg
1.72
3Y Avg
2.15
5Y Avg
2.15
Market Cap
$16.54M
Current Ratio
1.65
TTM Avg
3.34
3Y Avg
3.94
5Y Avg
7.05
Market Cap
$15.91M
Current Ratio
1.11
TTM Avg
2.09
3Y Avg
1.19
5Y Avg
1.02
Market Cap
$15.30M
Current Ratio
1.24
TTM Avg
4.22
3Y Avg
12.60
5Y Avg
18.98
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cosmos Health Inc. (COSM) | $18.82M | 1.05 | 1.02 | 1.25 | 1.24 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | 0.20 | 0.34 | 6.34 | 6.11 |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | 1.25 | 1.72 | 2.15 | 2.15 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | 2.48 | 1.52 | 2.21 | 4.42 |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | 1.65 | 3.34 | 3.94 | 7.05 |
| BioCardia, Inc. (BCDA)vs › | $16.22M | 2.09 | 1.13 | 1.21 | 2.30 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | 1.11 | 2.09 | 1.19 | 1.02 |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 1.13 | 1.19 | 1.11 | 1.05 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | 1.24 | 4.22 | 12.60 | 18.98 |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.20M | 26.25 | 8.96 | 10.61 | 33.19 |
Current Ratio
1.05
Quick Ratio
0.92
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.05 |
| 2026-03-31 | 1.08 |
| 2025-12-31 | 1.00 |
| 2025-09-30 | 0.99 |
| 2025-06-30 | 0.98 |
| 2025-03-31 | 1.05 |
| 2024-12-31 | 0.99 |
| 2024-09-30 | 1.44 |
| 2024-06-30 | 1.35 |
| 2024-03-31 | 1.46 |
| 2023-12-31 | 1.51 |
| 2023-09-30 | 2.06 |
| 2023-06-30 | 2.19 |
| 2023-03-31 | 2.73 |
| 2022-12-31 | 2.58 |
| 2022-09-30 | 1.05 |
| 2022-06-30 | 1.12 |
| 2022-03-31 | 1.40 |
| 2021-12-31 | 1.33 |
| 2021-09-30 | 1.18 |
| 2021-06-30 | 1.33 |
| 2021-03-31 | 1.21 |
| 2020-12-31 | 1.19 |
| 2020-09-30 | 0.87 |
| 2020-06-30 | 0.84 |
| 2020-03-31 | 0.73 |
| 2019-12-31 | 0.75 |
| 2019-09-30 | 0.73 |
| 2019-06-30 | 0.78 |
| 2019-03-31 | 0.83 |
| 2018-12-31 | 0.82 |
| 2018-09-30 | 1.31 |
| 2018-06-30 | 0.84 |
| 2018-03-31 | 0.68 |
| 2017-12-31 | 0.69 |
| 2017-09-30 | 0.74 |
| 2017-06-30 | 0.67 |
| 2017-03-31 | 0.56 |
| 2016-12-31 | 0.54 |
| 2016-09-30 | 0.53 |
| 2016-06-30 | 0.33 |
| 2016-03-31 | 0.32 |
| 2015-12-31 | 0.29 |
| 2015-09-30 | 3.85 |
| 2015-06-30 | 3.95 |
| 2015-03-31 | 4.06 |
| 2014-12-31 | 4.10 |
| 2014-09-30 | 4.73 |
| 2014-06-30 | 3.10 |
| 2014-03-31 | 2.05 |
| 2013-12-31 | 0.94 |
| 2013-09-30 | 0.36 |
| 2013-07-31 | 0.05 |
| 2013-04-30 | 0.02 |
| 2013-01-31 | 0.00 |
| 2012-10-31 | 0.00 |
| 2012-07-31 | 0.00 |
| 2012-04-30 | 0.01 |
| 2012-01-31 | 0.00 |
| 2011-10-31 | 0.05 |
| 2011-07-31 | 0.76 |
| 2011-04-30 | 12.29 |
| 2011-01-31 | 11.72 |
| 2010-10-31 | 0.04 |
| 2010-07-31 | 0.03 |
| 2010-04-30 | 0.55 |
| 2010-01-31 | 0.87 |
| 2009-10-31 | 0.00 |
